Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Starting treatment news

Show

From To
AIDS Healthcare Foundation Applauds WHO Decision to Initiate HIV Treatment Earlier

World Health Organization (WHO) announced this week at Treatment as Prevention conference in Vancouver, Canada, that it will raise treatment initiation guidelines for HIV-positive individuals from a CD4 count of less than 350 to a count of less than 500.

Published
25 April 2013
From
Wall Street Journal
London HIV drug prescribing changes – patient satisfaction and clinical outcomes maintained

Controversial changes to the range of anti-HIV drugs which are most commonly prescribed in London have resulted in a £7.2 million saving over two years, with no

Published
22 April 2013
By
Roger Pebody
Study: In Malawi lifelong antiretroviral treatment for expectant moms “translates into saving more than 250,000 maternal life years”

A cost-effectiveness analysis of Option B+ in Malawi.

Published
27 March 2013
From
Science Speaks
Self-testing and home treatment initiation triples uptake of HIV treatment in Malawi

Offering people the opportunity to self-test at home and then start antiretroviral therapy after counselling at home, together with home delivery of antiretroviral drugs, increased the number

Published
21 March 2013
By
Keith Alcorn
In resource-rich countries, migrants have a higher risk of progressing to AIDS in the first year of HIV therapy

Rates of AIDS-defining illnesses in the first year of antiretroviral therapy are significantly higher among migrant than non-migrant populations in resource-rich countries, investigators report in the online edition

Published
01 March 2013
By
Michael Carter
Meta-analysis shows superiority of integrase inhibitors in first-line HIV therapy and benefits for people changing treatment due to resistance

Antiretroviral combinations based on an integrase inhibitor are superior to other first-line HIV treatment regimens, according to the results of a meta-analysis published in the open access journal

Published
26 February 2013
By
Michael Carter
When to Start ART in Africa — An Urgent Research Priority

We believe that a randomized, controlled trial should be undertaken immediately to determine when to initiate ART in Africa for maximal individual health benefit. It is feasible to conduct a large, simple trial to assess the risks and benefits of immediate ART versus deferral until a CD4+ count of 350 cells per cubic millimeter is reached.

Published
23 February 2013
From
New England Journal of Medicine
Why no one is helped by dumbing down the “when to start” debate: a response to Dr Myron Cohen

This article was prompted by contributions to the “when to start” debate that avoid both it’s complexity and the lack of evidence for benefits at higher CD4 counts. This issue has broad concern for HIV positive people, doctors and health workers, and public health policy.

Published
23 February 2013
From
HIV i-Base
Earlier treatment in South African cohort did not increase loss to follow-up

Implementation of South Africa’s 2011 expansion of treatment guidelines – starting antiretroviral therapy (ART) at or below 350 cells/mm3 – will not increase patient loss to follow-up, researchers

Published
21 February 2013
By
Carole Leach-Lemens
Updated HIV Treatment Guidelines Include Stronger Recommendation for Acute Infection

Among the key changes are additional information about the most recently approved antiretroviral agents and a recommendation that newly infected people with HIV should be offered combination ART. The guidelines continue to recommend treatment for all people with HIV, both to reduce the risk of disease progressionand for the prevention of HIV transmission.

Published
15 February 2013
From
HIVandHepatitis.com
← First12345...56Next →

Filter by country